CALZETTA, Luigino
 Distribuzione geografica
Continente #
NA - Nord America 4.531
EU - Europa 2.273
AS - Asia 1.570
AF - Africa 27
SA - Sud America 21
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.432
Nazione #
US - Stati Uniti d'America 4.506
SG - Singapore 1.222
IE - Irlanda 1.084
SE - Svezia 473
IT - Italia 254
CN - Cina 252
FI - Finlandia 114
DE - Germania 82
AT - Austria 65
IN - India 40
GB - Regno Unito 39
EE - Estonia 38
FR - Francia 35
BE - Belgio 21
CA - Canada 21
CI - Costa d'Avorio 21
NL - Olanda 16
BR - Brasile 15
TR - Turchia 13
RU - Federazione Russa 12
ID - Indonesia 9
JP - Giappone 8
ES - Italia 7
HK - Hong Kong 6
IR - Iran 6
LT - Lituania 5
NZ - Nuova Zelanda 5
AR - Argentina 4
AU - Australia 4
CH - Svizzera 4
HR - Croazia 4
TW - Taiwan 4
UA - Ucraina 4
HU - Ungheria 3
MX - Messico 3
PT - Portogallo 3
ZA - Sudafrica 3
BG - Bulgaria 2
ET - Etiopia 2
IL - Israele 2
MK - Macedonia 2
RO - Romania 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
IQ - Iraq 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MM - Myanmar 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 8.432
Città #
Chandler 1.266
Dublin 1.074
Singapore 980
Santa Clara 422
Ashburn 351
Boardman 317
Princeton 256
Des Moines 144
Helsinki 113
Wilmington 89
Beijing 72
Vienna 65
Shanghai 64
Ann Arbor 59
Tallinn 38
Rome 33
Marseille 30
Parma 30
Chicago 29
Milan 29
Abidjan 21
Brussels 21
New York 21
Bremen 19
Fremont 19
Seattle 19
Redmond 18
Dallas 16
Los Angeles 15
Norwalk 15
Pune 15
Bologna 14
Rockville 13
Guangzhou 12
Naples 12
London 11
Saint Louis 10
Toronto 10
Nanchang 9
Borås 8
Edinburgh 8
Falls Church 8
Houston 8
Kocaeli 8
Phoenix 8
Grafing 7
Kolkata 7
Yogyakarta 7
Trecasali 6
Frankfurt am Main 5
Osaka 4
Ottawa 4
Solbiate Olona 4
St Petersburg 4
Turin 4
Vaddangi 4
Verona 4
Visakhapatnam 4
Washington 4
Zagreb 4
Barcelona 3
Bengaluru 3
Budapest 3
Cape Town 3
Central 3
Izmir 3
Jinan 3
Miami 3
Modena 3
Montechiarugolo 3
Munich 3
Nocera Inferiore 3
Porcari 3
Pozzuoli 3
Quartu Sant'Elena 3
Radeberg 3
Reggio Emilia 3
Shenyang 3
Sydney 3
São Paulo 3
Taipei 3
Tokyo 3
Zurich 3
Amsterdam 2
Andover 2
Arlington 2
Belsize Park 2
Boston 2
Caccamo 2
Cassino 2
Changsha 2
Chekhov 2
Chesham 2
Chiesina Uzzanese 2
Cipolletti 2
Columbus 2
Correggio 2
Council Bluffs 2
Cremona 2
Cumignano sul Naviglio 2
Totale 5.974
Nome #
Small airways in asthma: from bench-to-bedside 119
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 109
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients 102
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD 97
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients 82
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom 73
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 68
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study 64
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review 64
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 61
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea 59
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD 59
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system 58
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 57
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System 56
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab 56
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 55
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines 54
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume 54
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 54
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine 53
Analysis of exhaled breath fingerprints and volatile organic compounds in COPD 53
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 53
A 6MWT index to predict O-2 flow correcting exercise induced SpO(2) desaturation in ILD 52
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review 52
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 52
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence 51
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 51
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 50
Allergy in adolescent population (14-18 years) living in Campania region (southern Italy). A multicenter study 50
SMART for the treatment of asthma: A network meta-analysis of real-world evidence 50
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania” 50
Advances with glucocorticoids in the treatment of asthma: state of the art 50
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms 49
Cardiovascular disease in copd 49
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 48
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? 48
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies 47
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination 46
A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD 45
ANTI-INFLAMMATORY PROFILE OF N-ACETYLCYSTEINE IN HUMAN BRONCHI STIMULATED WITH LIPOPOLYSACCHARIDE 44
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 44
Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma 43
Onset of action of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in patients with COPD 43
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study 43
The impact of comorbidities on severe asthma 43
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 43
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 42
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD 42
Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma 42
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 42
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 42
ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 41
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? 41
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 40
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed 40
Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations 40
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate plus vilanterol for the treatment of asthma 40
Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? 40
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations 40
The possible concomitant use of aeroallergen and food panels for skin prick testing might enhance the risk of generalized allergic reactions in children 40
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients 40
Optimizing drug delivery in COPD: The role of inhaler devices 39
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile 39
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs 39
Sex differences in COPD management 39
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 39
A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ) 38
The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle 38
Is H1-antihistamine (desloratadine 5mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in "real life''? 38
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 38
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 38
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials 38
Unmet needs and relationship between general practitioners (GPS) and allergists living in Campania region (Southern Italy) 38
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 37
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 37
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways 37
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review 37
Are there pulmonary sequelae in patients recovering from COVID-19? 37
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment 36
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 36
LAMA/LABA Fixed Combinations for COPD Management: A Systematic Comparative Review 36
Emerging drugs for chronic obstructive pulmonary disease 36
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 36
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? 35
Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease 35
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 34
Pharmacology and Therapeutics of Bronchodilators 34
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 34
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 34
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 34
Step-up and step-down approaches in the treatment of asthma 34
Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link? 34
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 33
Pharmacogenetic and pharmacogenomic considerations of asthma treatment 33
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 33
Diabetes mellitus among outpatients with COPD attending a university hospital 33
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 33
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma 33
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis 33
Totale 4.680
Categoria #
all - tutte 53.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020198 0 0 0 0 0 0 0 0 1 7 1 189
2020/202194 0 0 0 7 3 3 0 19 32 20 5 5
2021/20221.118 1 10 2 20 76 39 257 75 46 3 37 552
2022/20233.941 509 313 229 258 277 455 48 276 1.378 28 134 36
2023/20241.415 100 161 56 65 141 259 103 82 63 99 102 184
2024/20252.110 49 330 454 273 543 461 0 0 0 0 0 0
Totale 8.883